MedTrace Logo

Adjunctive Ganglionated Plexus Ablation in Redo-Pulmonary Vein Isolation

NCT03535818 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2024-08-09

No results posted yet for this study

Summary

The investigator propose to test the efficacy of adjunctive ET-GP ablation in patients undergoing redo PVI for paroxysmal AF.

Conditions

Interventions

PROCEDURE

Radiofrequency ablation

RF application to achieve complete pulmonary vein isolation +/- ganglionated plexus ablation

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Prapa Kanagaratnam, PhD · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-14
Primary Completion
2026-02-01
Completion
2026-02-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03535818 on ClinicalTrials.gov